Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- XBiotech Inc. (NASDAQ:XBIT), developer of True Human™ therapeutic antibodies, today announced that enrollment has been completed in its randomized, double-blind, placebo-controlled Phase...
Dec 07, 2016 13:00 pm UTC| Business
AUSTIN, Texas, Dec. 07, 2016 -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat genetic rare diseases...
Dec 07, 2016 12:54 pm UTC| Business
RUTHERFORD, N.J., Dec. 07, 2016 -- Cancer Genetics, Inc. (Nasdaq:CGIX)(“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced a collaboration...
Dec 07, 2016 12:30 pm UTC| Business
OKLAHOMA CITY, Dec. 07, 2016 -- Gulfport Energy Corporation (Nasdaq:GPOR) (“Gulfport” or the “Company”) today announced that the Company has entered into a definitive agreement with a third-party to acquire...
Dec 07, 2016 12:30 pm UTC| Business
BEVERLY, Mass., Dec. 07, 2016 -- Cellceutix Corporation, (OTCQB:CTIX) (“the Company”), a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, anti-inflammatory, and...
Dec 07, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 07, 2016 -- Origent Data Sciences, Inc. (Origent) and Cytokinetics, Inc. (Nasdaq:CYTK) today announced results from the first part of a research collaboration to refine and...
Compass Lexecon and FTI Consulting Professionals Honored as Leading Women in Antitrust
Dec 07, 2016 12:30 pm UTC| Business
WASHINGTON, Dec. 07, 2016 -- FTI Consulting, Inc. (NYSE:FCN) today announced that three professionals from FTI Consulting and its subsidiary Compass Lexecon have been named to Global Competition Review’s Women in...